169 related articles for article (PubMed ID: 32680576)
21. Anti-inflammatory Fucoidan-ConA oral insulin nanosystems for smart blood glucose regulation.
Zhou J; Ma H; Guan M; Feng J; Dong X; Wei Y; Zhang T
Int J Pharm; 2024 Jun; 659():124250. PubMed ID: 38777304
[TBL] [Abstract][Full Text] [Related]
22. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
23. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
Rastogi R; Anand S; Koul V
Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
[TBL] [Abstract][Full Text] [Related]
24. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles.
Ahmad N; Mohd Amin MC; Ismail I; Buang F
Expert Opin Drug Deliv; 2016; 13(5):621-32. PubMed ID: 26943455
[TBL] [Abstract][Full Text] [Related]
27. A novel core-shell lipid nanoparticle for improving oral administration of water soluble chemotherapeutic agents: inhibited intestinal hydrolysis and enhanced lymphatic absorption.
Wang T; Shen L; Zhang Z; Li H; Huang R; Zhang Y; Quan D
Drug Deliv; 2017 Nov; 24(1):1565-1573. PubMed ID: 29029577
[TBL] [Abstract][Full Text] [Related]
28. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
[TBL] [Abstract][Full Text] [Related]
29. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
30. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.
Sharma G; van der Walle CF; Ravi Kumar MN
Int J Pharm; 2013 Jan; 440(1):99-110. PubMed ID: 22227604
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal Responsive Polymeric Nanoparticles for Oral Delivery of Insulin: Optimized Preparation, Characterization, and In Vivo Evaluation.
Fang Y; Wang Q; Lin X; Jin X; Yang D; Gao S; Wang X; Yang M; Shi K
J Pharm Sci; 2019 Sep; 108(9):2994-3002. PubMed ID: 31047941
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
Cui F; Shi K; Zhang L; Tao A; Kawashima Y
J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
[TBL] [Abstract][Full Text] [Related]
34. Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies.
Muntoni E; Marini E; Ahmadi N; Milla P; Ghè C; Bargoni A; Capucchio MT; Biasibetti E; Battaglia L
Acta Diabetol; 2019 Dec; 56(12):1283-1292. PubMed ID: 31407113
[TBL] [Abstract][Full Text] [Related]
35. A composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():37-45. PubMed ID: 27612686
[TBL] [Abstract][Full Text] [Related]
36. Poly(ester amide) blend microspheres for oral insulin delivery.
He P; Liu H; Tang Z; Deng M; Yang Y; Pang X; Chen X
Int J Pharm; 2013 Oct; 455(1-2):259-66. PubMed ID: 23876502
[TBL] [Abstract][Full Text] [Related]
37. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
[TBL] [Abstract][Full Text] [Related]
38. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
Singh S; Kushwah V; Agrawal AK; Jain S
Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
[TBL] [Abstract][Full Text] [Related]
39. Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study.
Rachmawati H; Haryadi BM; Anggadiredja K; Suendo V
AAPS PharmSciTech; 2015 Jun; 16(3):692-703. PubMed ID: 25511810
[TBL] [Abstract][Full Text] [Related]
40. Release profile of insulin from pH-sensitive hydrogel and its hypoglycemic effect by oral administration.
Shi Y; Wang X; Deng X; Tian R; Zhang Y; Shang Q; Chen N
J Biomater Sci Polym Ed; 2016; 27(1):86-96. PubMed ID: 26498982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
